Finance

Lists
Why is 000100 up 8.71%?
Dive Deeper
000100:KRX
Yuhan Corp
₩ 87,400.00
+8.71%
(+7,000.00) 1D
10-р сарын 19, 15:30:01 (GMT+9)  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000100...
Open
₩ 80,500
High
₩ 87,800
Low
₩ 79,800
Mkt. cap
6.52ИН
Avg. vol.
207.75 мян
Volume
975.64 мян
Dividend
0.69%
Quarterly dividend
₩ 150
Ex-dividend date
2026 оны 2-р сарын 26
P/E ratio
27.47
52-wk high
₩ 129,200
52-wk low
₩ 65,000
EPS
₩ 3,181
Shares outstanding
73.62 сая
No. of employees
2 мян
Open
₩ 80,500
High
₩ 87,800
Low
₩ 79,800
Mkt. cap
6.52ИН
Avg. vol.
207.75 мян
Volume
975.64 мян
Dividend
0.69%
Quarterly dividend
₩ 150
Ex-dividend date
2026 оны 2-р сарын 26
P/E ratio
27.47
52-wk high
₩ 129,200
52-wk low
₩ 65,000
EPS
₩ 3,181
Shares outstanding
73.62 сая
No. of employees
2 мян
News stories
From web sources and news partners
Profile
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
About Yuhan Corp
CEOWook Je Cho
Employees2.08 мян
Founded1926
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
570.01Т
546.07Т
526.78Т
639.45Т
Cost of goods sold
401.57Т
333.27Т
377.63Т
411.75Т
Cost of revenue
401.57Т
333.27Т
377.63Т
411.75Т
Research and development expenses
45.94 тэрбум
78.04 тэрбум
47.24 тэрбум
60.12 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
94.69 тэрбум
103.16Т
88.43 тэрбум
99.40 тэрбум
Operating expense
146.43Т
185.79Т
140.37Т
160.70Т
Total operating expenses
548.00Т
519.05Т
518.00Т
572.45Т
Operating income
22.01 тэрбум
27.02 тэрбум
8.78 тэрбум
67.00 тэрбум
Other non operating income
-2.09 тэрбум
-4.58 тэрбум
231.25 сая
-6.59 тэрбум
EBT including unusual items
35.18 тэрбум
120.91Т
28.76 тэрбум
88.37 тэрбум
EBT excluding unusual items
34.24 тэрбум
112.36Т
26.45 тэрбум
84.89 тэрбум
Income tax expense
14.01 тэрбум
10.77 тэрбум
5.39 тэрбум
20.33 тэрбум
Effective tax rate
39.83%
8.91%
18.75%
23.00%
Other operating expenses
1.68 тэрбум
3.00 тэрбум
1.94 тэрбум
2.87 тэрбум
Net income
25.28 тэрбум
114.43Т
27.04 тэрбум
70.32 тэрбум
Net profit margin
4.44%
20.96%
5.13%
11.00%
Earnings per share
348.00
1.53 мян
372.00
950.00
Interest and investment income
2.11 тэрбум
2.13 тэрбум
2.35 тэрбум
2.47 тэрбум
Interest expense
-3.99 тэрбум
-3.91 тэрбум
-3.86 тэрбум
-3.89 тэрбум
Net interest expenses
-1.88 тэрбум
-1.77 тэрбум
-1.51 тэрбум
-1.42 тэрбум
Depreciation and amortization charges
2.12 тэрбум
962.24 сая
1.52 тэрбум
1.48 тэрбум
EBITDA
40.00 тэрбум
44.17 тэрбум
27.88 тэрбум
90.47 тэрбум
Gain or loss from assets sale
9.44 сая
-9.65 тэрбум
15.64 сая
291.06 сая
AI content may include mistakes. Learn more
Google аппс